STADA confirms Bain/Cinven mulling to apply for exemption from one-year exclusion period for renewed offer submission
04 JUL 2017
STADA Arzneimittel AG [ETR:SAZ] confirms that Nidda Healthcare Holding AG, the acquiring company of Bain Capital and Cinven, gave notice to be considering to submit an application to the German Federal Financial Supervisory Authority (BaFin) for an exemption from the one-year exclusion period to make a renewed voluntary public takeover offer under section 26(2) of the German Securities Acquisition and Takeover Act (WpÜG).
STADA is currently assessing whether the company would give its consent to the exemption from the exclusion period and will keep both the capital market and the public updated on further progress in this regard, in line with the applicable legal requirements.